Get Email Alerts
Links to Other Information About Aplastic Anemia
NHLBI Resources
- Anemia (Health Topics)
- Blood Transfusion (Health Topics)
- Blood and Marrow Stem Cell Transplant (Health Topics)
- Fanconi Anemia (Health Topics)
- NHLBI-Related Public Interest Organizations
Non-NHLBI Resources
- Anemia (MedlinePlus)
Clinical Trials
- Children and Clinical Studies
- Clinical Trials (Health Topics)
- Current Research (ClinicalTrials.gov)
- NHLBI Clinical Trials
- NHLBI Pediatric Clinical Trials
- NIH Clinical Research Trials and You (National Institutes of Health)
- ResearchMatch (funded by the National Institutes of Health)
Featured Video
Clinical Trials for Rare Blood Diseases (Neal Young, M.D.)
Clinical trials are research studies that explore whether a medical strategy, treatment, or device is safe and effective for humans. To find clinical trials that are currently underway for Aplastic Anemia, visit www.clinicaltrials.gov.
July 4, 2012
NIH Media Availability: Platelet drug shows clinical benefits for severe, unresponsive aplastic anemia
Eltrombopag, a drug that was designed to stimulate production of platelets from the bone marrow and thereby improve blood clotting, can raise blood cell levels in some people with severe aplastic anemia who have failed all standard therapies.
The NHLBI updates Health Topics articles on a biennial cycle based on a thorough review of research findings and new literature. The articles also are updated as needed if important new research is published. The date on each Health Topics article reflects when the content was originally posted or last revised.
Twitter
Facebook
YouTube
Google+